PL3894424T3 - Sól mesylanowa związku aminolupanowego o działaniu hamującym dojrzewanie hiv - Google Patents
Sól mesylanowa związku aminolupanowego o działaniu hamującym dojrzewanie hivInfo
- Publication number
- PL3894424T3 PL3894424T3 PL19823817.2T PL19823817T PL3894424T3 PL 3894424 T3 PL3894424 T3 PL 3894424T3 PL 19823817 T PL19823817 T PL 19823817T PL 3894424 T3 PL3894424 T3 PL 3894424T3
- Authority
- PL
- Poland
- Prior art keywords
- lupane
- amino
- compound
- inhibitory activity
- mesylate salt
- Prior art date
Links
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862777432P | 2018-12-10 | 2018-12-10 | |
| US201962874557P | 2019-07-16 | 2019-07-16 | |
| PCT/IB2019/060564 WO2020121161A1 (en) | 2018-12-10 | 2019-12-09 | Mesylate salt of an amino-lupane compound with hiv maturation inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3894424T3 true PL3894424T3 (pl) | 2023-05-02 |
Family
ID=68944386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19823817.2T PL3894424T3 (pl) | 2018-12-10 | 2019-12-09 | Sól mesylanowa związku aminolupanowego o działaniu hamującym dojrzewanie hiv |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220024970A1 (pl) |
| EP (1) | EP3894424B1 (pl) |
| JP (1) | JP2022510475A (pl) |
| CY (1) | CY1125952T1 (pl) |
| DK (1) | DK3894424T3 (pl) |
| ES (1) | ES2938486T3 (pl) |
| FI (1) | FI3894424T3 (pl) |
| HR (1) | HRP20230208T1 (pl) |
| HU (1) | HUE061184T2 (pl) |
| LT (1) | LT3894424T (pl) |
| PL (1) | PL3894424T3 (pl) |
| PT (1) | PT3894424T (pl) |
| RS (1) | RS64113B1 (pl) |
| SI (1) | SI3894424T1 (pl) |
| SM (1) | SMT202300049T1 (pl) |
| WO (1) | WO2020121161A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL150524A0 (en) * | 2000-01-07 | 2003-02-12 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| WO2014184553A1 (en) * | 2013-05-15 | 2014-11-20 | Cipla Limited | Pharmaceutical antiretroviral compositions |
| MX374543B (es) * | 2014-04-11 | 2025-03-06 | Viiv Healthcare Uk No 4 Ltd | Triterpenoides con actividad inhibidora de la maduración del virus de inmunodeficiencia humana, sustituidos en la posición 3 con un anillo no aromático que lleva un sustituyente haloalquilo. |
-
2019
- 2019-12-09 RS RS20230264A patent/RS64113B1/sr unknown
- 2019-12-09 WO PCT/IB2019/060564 patent/WO2020121161A1/en not_active Ceased
- 2019-12-09 LT LTEPPCT/IB2019/060564T patent/LT3894424T/lt unknown
- 2019-12-09 EP EP19823817.2A patent/EP3894424B1/en active Active
- 2019-12-09 SM SM20230049T patent/SMT202300049T1/it unknown
- 2019-12-09 US US17/296,627 patent/US20220024970A1/en not_active Abandoned
- 2019-12-09 ES ES19823817T patent/ES2938486T3/es active Active
- 2019-12-09 SI SI201930452T patent/SI3894424T1/sl unknown
- 2019-12-09 PL PL19823817.2T patent/PL3894424T3/pl unknown
- 2019-12-09 DK DK19823817.2T patent/DK3894424T3/da active
- 2019-12-09 JP JP2021532391A patent/JP2022510475A/ja active Pending
- 2019-12-09 FI FIEP19823817.2T patent/FI3894424T3/fi active
- 2019-12-09 HU HUE19823817A patent/HUE061184T2/hu unknown
- 2019-12-09 HR HRP20230208TT patent/HRP20230208T1/hr unknown
- 2019-12-09 PT PT198238172T patent/PT3894424T/pt unknown
-
2023
- 2023-03-23 CY CY20231100158T patent/CY1125952T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS64113B1 (sr) | 2023-04-28 |
| ES2938486T3 (es) | 2023-04-11 |
| LT3894424T (lt) | 2023-03-10 |
| HUE061184T2 (hu) | 2023-05-28 |
| US20220024970A1 (en) | 2022-01-27 |
| FI3894424T3 (fi) | 2023-04-25 |
| PT3894424T (pt) | 2023-02-28 |
| SMT202300049T1 (it) | 2023-03-17 |
| SI3894424T1 (sl) | 2023-04-28 |
| WO2020121161A1 (en) | 2020-06-18 |
| CY1125952T1 (el) | 2024-09-20 |
| JP2022510475A (ja) | 2022-01-26 |
| HRP20230208T1 (hr) | 2023-04-14 |
| EP3894424B1 (en) | 2023-01-25 |
| EP3894424A1 (en) | 2021-10-20 |
| DK3894424T3 (da) | 2023-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202003096UA (en) | Methods of treating immunotherapy-related toxicity using a gm-csf antagonist | |
| EP3240412A4 (en) | Use of picolinamide compounds with fungicidal activity | |
| EP3240420A4 (en) | Use of picolinamide compounds with fungicidal activity | |
| GB2588505B (en) | Preparation of psilocybin | |
| IL276592A (en) | History of Subtirum | |
| ZA201804943B (en) | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar | |
| SG11202102317PA (en) | Methods of treating immunotherapy-related toxicity using a gm-csf antagonist | |
| IL290692A (en) | Salt | |
| IL280025A (en) | A xinafoate salt of a jak inhibiting compound | |
| ZA202105399B (en) | Use of spiropidion | |
| PL3424930T3 (pl) | Kryształ związku wykazującego aktywność hamującą JAK | |
| PL3445766T3 (pl) | Nowy związek przeciwdrobnoustrojowy | |
| GB2570868B (en) | Tackle shield | |
| ZA201800163B (en) | New anti-malarial agents | |
| EP4003140A4 (en) | Sternal ascender apparatus | |
| IL274084A (en) | Comb for the treatment of dandruff | |
| SI3894424T1 (sl) | Mezilatna sol amino-lupanske spojine z zaviralno aktivnostjo dozorevanja HIV-a | |
| PT3784349T (pt) | Compostos com atividade inibidora de maturação do hiv | |
| IL276195A (en) | Salt forms of an organic compound | |
| GB201819757D0 (en) | Compounds with antimicrobial activity | |
| IL260405A (en) | None-abusive derivatives of ritalin | |
| GB201917107D0 (en) | Process for shelf-life extention of fish | |
| FI12569U1 (fi) | Uistin | |
| GB201904190D0 (en) | Salt | |
| HK40025473A (en) | Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |